CD4+ T cells from glutamic acid decarboxylase (GAD)65 -specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer

Journal of Experimental Medicine

Volumn 196, Issue 4, 2002, Pages 481-492

  Tarbell, Kristin V ^a   Lee, Mark ^a   Ranheim, Erik ^a   Chao, Cheng Chi ^a   Sanna, Maija ^a   Kim, Seon Kyeong ^a   Dickie, Peter ^b   Teyton, Luc ^c   Davis, Mark ^a   Mcdevitt, Hugh ^a,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d Department of Immunology ^*  (United States)

Author keywords

Autoimmunity; CD152; IL 10; Mouse, NOD; T lymphocytes, regulatory

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPITOPE; GAMMA INTERFERON; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; INTERLEUKIN 10; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DIABETOGENESIS; INSULITIS; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CYTOKINES; DIABETES MELLITUS; EPITOPES, T-LYMPHOCYTE; GENE EXPRESSION; GLUTAMATE DECARBOXYLASE; IMMUNOCONJUGATES; ISOENZYMES; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, INTERLEUKIN-2;

EID: 0037136283     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20011845     Document Type: Article

References (60)

1. Insulin-dependent diabetes mellitus
2. Type-I diabetes: A chronic autoimmune disease of human, mouse, and rat
3. + T cells
4. + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice
5. Checkpoints in the progression of autoimmune disease: Lessons from diabetes models
6. Mouse and man: Multiple genes and multiple autoantigens in the aetiology of type I DM and related autoimmune disorders
7. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice
8. T cell-mediated maintenance of natural self-tolerance: Its breakdown as a possible cause of various autoimmune diseases
9. + immunoregulatory T cells that control autoimmune diabetes
10. A glutamic acid decarboxylase 65-specific Th2 cell clone immunoregulates autoimmune diabetes in nonobese diabetic mice
11. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
12. Th1 to Th2 cytokine shifts in nonobese diabetic mice: Sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation
13. Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors
14. Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool
15. + islet-specific T cell clone
16. Following a diabetogenic T cell from genesis through pathogenesis
17. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity
18. T-cell responses to autoantigens in IDDM. The search for the Holy Grail
19. Islet cell autoantigens in insulin-dependent diabetes
20. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies
21. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice
22. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library
23. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
24. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice
25. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulindependent diabetes
26. Antiislet autoantibodies usually develop sequentially rather than simultaneously
27. Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)
28. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes
29. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells
30. + Th1 cells induce diabetes in NOD/SCID mice
31. Identification of immunogenic epitopes of GAD 65 presented by I-Ag7 in nonobese diabetic mice
32. The role of MHC class II molecules in susceptibility to type I diabetes: Identification of peptide epitopes and characterization of the T cell repertoire
33. Cassette vectors directing expression of T cell receptor genes in transgenic mice
34. The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder
35. Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice
36. Expression of a second receptor rescues self-specific T cells from thymic deletion and allows activation of autoreactive effector function
37. + T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis
38. A range of CD4 T cell tolerance: Partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis
39. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice
40. Peripheral tolerance as a multi-step mechanism
41. Deletion of high-avidity T cells by thymic epithelium
42. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy
43. Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice
44. + T cells
45. + regulatory T cells is mediated by cell surface-bound transforming growth factor β
46. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
47. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation
48. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis
49. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-γ transcription
50. Establishment of islet-specific T-cell lines and clones from islet isografts placed in spontaneously diabetic NOD mice
51. Diabetogenic T-cell clones
52. Antigen-specific mediated suppression of β cell autoimmunity by plasmid DNA vaccination
53. Plasmid dnas encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice
54. Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease
55. Expression of two T cell receptor α chains: Dual receptor T cells
56. Dual T cell receptor α chain T cells in autoimmunity
57. Expression of two α chains on the surface of T cells in T cell receptor transgenic mice
58. Allelic inclusion of T cell receptor alpha genes poses an autoimmune hazard due to low-level expression of autospecific receptors
59. Regulatory T cells in autoimmunity